The global angiographic catheters market is likely to reach USD 2,215.4 million by 2033, up from USD 1,451.0 million in 2023, advancing at a CAGR of 4.3% during the forecast period.
The angiographic catheters provide therapeutic agents and radiopaque media to the selected sites in the vascular system, and the same is catching the attention of market players. In addition, the angiographic catheter is also used to lead a guide wire to the targeted site, and the demand for angiographic catheters is gaining momentum as they are also used for the treatment of cardiac diseases.
The thin wall structure of the catheter allows the flow rate up to 23 ml/sec (saline), in turn widening its application, resulting in an upsurge in sales of these catheters. The market growth is further fostered by the rising demand for these catheters owing to the availability of angiographic catheters in different shapes.
Attributes | Details |
---|---|
Angiographic Catheters Market Share (2022) | USD 1,402.8 million |
Angiographic Catheters Market Share (2023) | USD 1,451.0 million |
Angiographic Catheters Market Share (2033) | USD 2,215.4 million |
Angiographic Catheters Market Share (2023 to 2033) | 4.3% |
The angiographic catheters demand analysis is swayed by the aid provided by it in combining the diagnosis and treatment in a single procedure and making possible, detailed, and accurate pictures of the blood vessels. The elimination of the need for any surgery by angiographic catheters is also considered to significantly impact the demand for the product worldwide.
The global market for angiographic catheters is expected to witness moderate growth over the forecast period due to the increasing adoption of angiographic procedures. External factors such as the increasing use of e-commerce and logistics services in developing and under-developing economies are also fuelling the angiographic catheter market growth.
Increased potential for the expansion of the angiographic catheter market is likely to result from the rise in research and development activities. Most research and development efforts are focused on a method that pinpoints the exact location of the bleeding and can be applied to medical procedures like embolization or vasopressin injection, auguring well for future market trends.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
A surge in the incidence of cardiac vascular diseases (CVDs) and a rise in demand for accurate diagnosis and procedural equipment in the global healthcare sector are increasing the sales of angiographic catheters. The government's growing efforts to raise public awareness also have a significant impact on the market growth rate for angiographic catheters.
The angiographic catheter market size is expanded with the development of technology which is another important aspect. However, the high cost of angiographic procedures and other components may hamper the growth of the global angiographic catheter market.
In addition to this, the availability of alternative therapies and complications associated with angiographic catheters can also dwindle the global angiographic catheters market size.
Due to the increased adoption of cutting-edge technology and the concentration of key market players in North America, this area held a monopoly on the angiographic catheter market, with a share of 33.1% captured in 2022.
The incidence of cardiovascular disorders is rising, and the number of elderly people is expanding, both of which are likely to accelerate the region’s market growth. The region’s angiographic catheter market trends are shaped by the rapid introduction of new products to the market, being accelerated by the strong Research and Development investment in the industry.
Western Europe is expected to be the second largest market for angiographic catheters due to the increasing government support for people undergoing coronary angioplasty through reimbursement and thus contributing to the region's angiographic catheters market share of 28.2% captured in 2022.
In addition, the aging population base and rising sterile and disposable catheter demand support the market expansion. The angiographic catheter market's technological developments are also likely to open up a wide array of market opportunities in the area.
Business models vary throughout time, sometimes as a consequence of changes in the market and other times as a result of the introduction of new technology, which leads to the formation of fresh, intriguing trends.
FDA-approved and CE-marked products are available. In June 2014, it was purchased by Spectranetics.
James K. Min, MD, the head of the Dalio Institute for Cardiac Imaging at New York Presbyterian Hospital/Weill Cornell Medical College, founded Cleerly in 2017. The business, which employs 60 people and has a total funding of USD 54 million, uses A.I. to interpret intricate heart CT scans.
The start-up's goal is to provide analysis of finely detailed images of the human heart that have been looked at by artificial intelligence. This research is based on pictures obtained using a Cardiac Computer Tomography Angiogram (CTA), a relatively new but quickly expanding method of detecting plaques.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
In recent years, manufacturers have improved the surface properties of angiographic catheters. The market for angiographic catheters is very fragmented and has only a few prominent players.
Recent developments in the market are :
Attribute | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2018 to 2022 |
Market Analysis | USD Million for Value |
Key Regions Covered | North America; Latin America; Europe; Asia Pacific; Middle East & Africa (MEA) |
Key Countries Covered | United States, Canada, Germany, United Kingdom, Nordic, Russia, BENELUX, Poland, France, Spain, Italy, Czech Republic, Hungary, Rest of EMEAI, Brazil, Peru, Argentina, Mexico, South Africa, Northern Africa, GCC Countries, China, Japan, South Korea, India, ASEAN, Thailand, Malaysia, Indonesia, Australia, New Zealand, Others |
Key Segments Covered | Product Type, End-use, Region |
Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, Trend Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
The market is likely to reach USD 2,215.4 million by 2033.
Key players include AngioDynamics Inc., Medtronic, Terumo Europe NV, and more.
Scoring balloon catheters and cutting balloon catheters are key segments.
Increasing adoption of hybrid operating rooms bolsters the market.
Key Asian countries include China, Japan, and South Korea.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Scoring Balloon Catheters 5.2. Cutting Balloon Catheters 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Use 6.1. Hospitals 6.2. Ambulatory Surgical Centers 6.3. Specialty Clinics 6.4. Others 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. North America 7.2. Latin America 7.3. Western Europe 7.4. Eastern Europe 7.5. South Asia and Pacific 7.6. East Asia 7.7. Middle East and Africa 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Key Countries Market Analysis 16. Market Structure Analysis 17. Competition Analysis 17.1. AngioDynamics, Inc. 17.2. Terumo Europe NV 17.3. Medtronic 17.4. Merit Medical Systems, Inc. 17.5. OSCOR Inc. 17.6. B. Braun Melsungen AG 17.7. Cardinal Health 17.8. InSitu Technologies Inc. 17.9. BVM Medical Limited 17.10. Precision Extrusion Inc. 17.11. Cardiva 17.12. C. R. Bard, Inc. 17.13. Boston Scientific Corporation 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports